CHA Comments on Stimulant Medication Shortages

Children’s health groups are asking HHS and the DEA to convene stakeholders to identify actionable solutions about ongoing stimulant medication shortages.
Download

Children's Hospital Association and other children’s health groups submitted joint comments to the Department of Health and Human Services (HHS) and the Drug Enforcement Administration (DEA) requesting the convening of stakeholders to identify actionable solutions about ongoing stimulant medication shortages.

Our comments highlight the long-term negative impacts that children and their families may experience due to untreated attention deficit hyperactivity disorder and that these shortages exacerbate existing health disparities among families enrolled in Medicaid and CHIP.

Related Content

When Millimeters Matter: Pharmacy Teams Power Pediatric Care

Pharmacy teams at children’s hospitals handle tens of millions of medication doses for our nation's kids.

Oct. 22, 2025

Four Years On: Children’s Mental Health Remains a National Emergency

Children nationwide continue to struggle with anxiety, depression, suicidal thoughts, and other mental health conditions.

Oct. 20, 2025

6 Pediatric Medicine Breakthroughs Made Possible by Federal Research Funding

Life-changing scientific innovations from children’s hospitals show how public investment changes lives.

Oct. 14, 2025